1. Home
  2. ACR vs ACOG Comparison

ACR vs ACOG Comparison

Compare ACR & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$19.01

Market Cap

134.4M

Sector

Real Estate

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$6.45

Market Cap

110.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACR
ACOG
Founded
2005
2000
Country
United States
Canada
Employees
N/A
57
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
134.4M
110.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACR
ACOG
Price
$19.01
$6.45
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$24.50
$18.00
AVG Volume (30 Days)
16.0K
53.1K
Earning Date
04-29-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$146.05
Revenue Next Year
N/A
$127.74
P/E Ratio
$19.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.51
$3.75
52 Week High
$24.61
$10.88

Technical Indicators

Market Signals
Indicator
ACR
ACOG
Relative Strength Index (RSI) 46.65 65.38
Support Level $18.73 $5.00
Resistance Level $18.98 $6.59
Average True Range (ATR) 0.39 0.46
MACD 0.00 0.06
Stochastic Oscillator 20.60 96.84

Price Performance

Historical Comparison
ACR
ACOG

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: